Nussbaum Ran

10% owner at LB PHARMACEUTICALS INC · on record since Sep 11, 2025
10% owner at Arno Therapeutics, Inc · on record since Sep 8, 2016
Director at Kite Pharma, Inc. · on record since Jun 27, 2014
Director at LB PHARMACEUTICALS INC · on record since Jun 5, 2026
Director at VBI VACCINES INC. · on record since Oct 31, 2017
Director at Eloxx Pharmaceuticals, Inc. · on record since Dec 29, 2017
Director at ARQULE INC · on record since Nov 20, 2017
Director at UroGen Pharma Ltd. · on record since Jan 10, 2019
Director at Prevail Therapeutics Inc. · on record since Jun 19, 2019
Director at Keros Therapeutics, Inc. · on record since Apr 13, 2020
10% owner at Keros Therapeutics, Inc. · on record since Apr 13, 2020

Insider trading activity of Nussbaum Ran

Transactions on record: 164; since Jun 27, 2014

Open-market buys: 35; $40M

Open-market sells: 11; $28.6M

Companies traded: 7; last filing Jun 5, 2026

Figures computed from official regulatory filings — .

Companies where Nussbaum Ran has traded

LB PHARMACEUTICALS INC5 tx · $15M · Jun 5, 2026
Keros Therapeutics, Inc.38 tx · $7M · Jun 6, 2025
UroGen Pharma Ltd.19 tx · $322.7K · Feb 28, 2023
Eloxx Pharmaceuticals, Inc.23 tx · $13.3M · Jun 17, 2022
Prevail Therapeutics Inc.3 tx · Jan 26, 2021
41 tx · $185M · Jan 16, 2020
35 tx · $41.1M · Oct 5, 2017

Track record of Nussbaum Ran

Statistical track record

Free account

Open-market buys: 35

Last buy: Sep 12, 2025

Win rates, median returns and the proven-insider analysis come with a free account.

Transaction history of Nussbaum Ran

Co-insiders of Nussbaum Ran

This page republishes public regulatory disclosures.

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
LB PHARMACEUTICALS INCListing unverified	Jun 5, 2026	AwardD (derivative)	10,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
LB PHARMACEUTICALS INCListing unverified	Sep 16, 2025	OtherD (derivative)	-10,000,000	—	n/a (No price was disclosed in the filing)		SEC
LB PHARMACEUTICALS INCListing unverified	Sep 16, 2025	Other	411,681	—	n/a (No price was disclosed in the filing)		SEC
LB PHARMACEUTICALS INCListing unverified	Sep 16, 2025	Buy	1,000,000	15.00 USD	$15M	conv 86ClusterUnusual size+1	SEC
LB PHARMACEUTICALS INCListing unverified	Sep 12, 2025	AwardD (derivative)	22,449	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Keros Therapeutics, Inc.Listing on record	Jun 6, 2025	Award	5,250	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Keros Therapeutics, Inc.Listing on record	Jun 6, 2025	AwardD (derivative)	10,500	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Keros Therapeutics, Inc.Listing on record	Jun 3, 2024	AwardD (derivative)	10,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Keros Therapeutics, Inc.Listing on record	Jun 8, 2023	AwardD (derivative)	10,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
UroGen Pharma Ltd.Listing on record	Feb 28, 2023	Exercise	2,211	5.00 USD	$11.1K		SEC
UroGen Pharma Ltd.Listing on record	Feb 28, 2023	ExerciseD (derivative)	-15,276	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
UroGen Pharma Ltd.Listing on record	Feb 28, 2023	ExerciseD (derivative)	-1,030	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
UroGen Pharma Ltd.Listing on record	Feb 28, 2023	ExerciseD (derivative)	-2,211	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
UroGen Pharma Ltd.Listing on record	Feb 28, 2023	Exercise	1,030	5.00 USD	$5.2K		SEC
UroGen Pharma Ltd.Listing on record	Feb 28, 2023	Exercise	47,999	5.94 USD	$285.1K		SEC
UroGen Pharma Ltd.Listing on record	Feb 28, 2023	ExerciseD (derivative)	-32,723	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Keros Therapeutics, Inc.Listing on record	Nov 30, 2022	Other	-3,539	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Keros Therapeutics, Inc.Listing on record	Nov 30, 2022	Other	-1,723	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Keros Therapeutics, Inc.Listing on record	Nov 30, 2022	OtherD (derivative)	-1,914	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Keros Therapeutics, Inc.Listing on record	Nov 30, 2022	OtherD (derivative)	-1,723	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Keros Therapeutics, Inc.Listing on record	Nov 30, 2022	OtherD (derivative)	-3,539	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Keros Therapeutics, Inc.Listing on record	Nov 30, 2022	Other	-1,914	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
UroGen Pharma Ltd.Listing on record	Aug 25, 2022	ExerciseD (derivative)	-1,030	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
UroGen Pharma Ltd.Listing on record	Aug 25, 2022	Exercise	1,030	5.00 USD	$5.2K		SEC
Eloxx Pharmaceuticals, Inc.Listing on record	Jun 17, 2022	AwardD (derivative)	20,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
LB PHARMACEUTICALS INCListing unverified	Jun 5, 2026	AwardD (derivative)	10,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
LB PHARMACEUTICALS INCListing unverified	Sep 16, 2025	OtherD (derivative)	-10,000,000	—	n/a (No price was disclosed in the filing)		SEC
LB PHARMACEUTICALS INCListing unverified	Sep 16, 2025	Other	411,681	—	n/a (No price was disclosed in the filing)		SEC
LB PHARMACEUTICALS INCListing unverified	Sep 16, 2025	Buy	1,000,000	15.00 USD	$15M	conv 86ClusterUnusual size+1	SEC
LB PHARMACEUTICALS INCListing unverified	Sep 12, 2025	AwardD (derivative)	22,449	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Keros Therapeutics, Inc.Listing on record	Jun 6, 2025	Award	5,250	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Keros Therapeutics, Inc.Listing on record	Jun 6, 2025	AwardD (derivative)	10,500	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Keros Therapeutics, Inc.Listing on record	Jun 3, 2024	AwardD (derivative)	10,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Keros Therapeutics, Inc.Listing on record	Jun 8, 2023	AwardD (derivative)	10,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
UroGen Pharma Ltd.Listing on record	Feb 28, 2023	Exercise	2,211	5.00 USD	$11.1K		SEC
UroGen Pharma Ltd.Listing on record	Feb 28, 2023	ExerciseD (derivative)	-15,276	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
UroGen Pharma Ltd.Listing on record	Feb 28, 2023	ExerciseD (derivative)	-1,030	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
UroGen Pharma Ltd.Listing on record	Feb 28, 2023	ExerciseD (derivative)	-2,211	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
UroGen Pharma Ltd.Listing on record	Feb 28, 2023	Exercise	1,030	5.00 USD	$5.2K		SEC
UroGen Pharma Ltd.Listing on record	Feb 28, 2023	Exercise	47,999	5.94 USD	$285.1K		SEC
UroGen Pharma Ltd.Listing on record	Feb 28, 2023	ExerciseD (derivative)	-32,723	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Keros Therapeutics, Inc.Listing on record	Nov 30, 2022	Other	-3,539	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Keros Therapeutics, Inc.Listing on record	Nov 30, 2022	Other	-1,723	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Keros Therapeutics, Inc.Listing on record	Nov 30, 2022	OtherD (derivative)	-1,914	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Keros Therapeutics, Inc.Listing on record	Nov 30, 2022	OtherD (derivative)	-1,723	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Keros Therapeutics, Inc.Listing on record	Nov 30, 2022	OtherD (derivative)	-3,539	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Keros Therapeutics, Inc.Listing on record	Nov 30, 2022	Other	-1,914	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
UroGen Pharma Ltd.Listing on record	Aug 25, 2022	ExerciseD (derivative)	-1,030	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
UroGen Pharma Ltd.Listing on record	Aug 25, 2022	Exercise	1,030	5.00 USD	$5.2K		SEC
Eloxx Pharmaceuticals, Inc.Listing on record	Jun 17, 2022	AwardD (derivative)	20,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC